vTv Therapeutics
Price & Volume
Stats
See more52W Range | $12.12-$29.19 |
Market Cap | $45.8M |
Shares Short | 27,933 |
Financials
See moreRevenue (12 Mos) | $1M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$9.9M |
Diluted EPS | -$4.37 |
News
See moreYahoo Finance • 8 days ago
vTv Therapeutics Announces 2024 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
Yahoo Finance • 11 days ago
vTv Therapeutics Announces FDA has Lifted Clinical Hold on Cadisegliatin Program for Diabetes
Yahoo Finance • last year
vTv Therapeutics Announces 2023 Third Quarter Financial Results and Provides Corporate Update
Yahoo Finance • last year
vTv Therapeutics to Participate at the Stifel 2023 Healthcare Conference
About
CEO | Mr. Paul J. Sekhri M.Sc. |
Address | 3980 Premier Drive, High Point, NC, United States, 27265 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 23 |
